XML 20 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Discontinued Operations: Closure of Direct Dose Rx
12 Months Ended
Dec. 31, 2022
Discontinued Operations: Closure of Direct Dose Rx [Abstract]  
DISCONTINUED OPERATIONS: Closure of Direct Dose Rx

4. DISCONTINUED OPERATIONS: Closure of Direct Dose Rx

 

On June 24, 2021, the Company’s Board of Directors decided effective immediately to close its pharmacy operations dba Direct Dose Rx. Immediately thereafter, Direct Dose Rx began transitioning its customers to other providers and began the process of closing its operations. Direct Dose

 

was launched as a start-up pharmacy primarily to deliver medications and vitamins to patients being discharged from skilled nursing facilities. The Company does not believe that the costs associated with such closure will be material. Based on the Company’s review and analysis of ASC 205-20 Presentation of Discontinued Operations it concluded to present the discontinued operations separately.

 

   Year Ended 
   December 31, 
   2022   2021 
   (in thousands) 
     
Revenues (discontinued operations)  $
   $370 
Operating Expense (discontinued operations)   (16)   641 
Income/loss from operations of discontinued operations, net of taxes  $16   $(271)